• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性耐多药结核病——俄罗斯伊万诺沃州,1999年

Primary multidrug-resistant tuberculosis--Ivanovo Oblast, Russia, 1999.

出版信息

MMWR Morb Mortal Wkly Rep. 1999 Aug 6;48(30):661-4.

PMID:10488782
Abstract

The incidence of tuberculosis (TB) in the Russian Federation has increased steadily from 34 per 100,000 population in 1991 to 78 per 100,000 in 1998 (Central Tuberculosis Research Institute, unpublished data, 1999). To reverse this trend, in 1995, federal and local governments, with assistance from the World Health Organization (WHO), implemented a pilot project using the WHO TB-control strategy of directly observed therapy, short-course (DOTS) in Ivanovo oblast (1998 population: approximately 1.3 million), a district 165 miles (280 km) northeast of Moscow. This report documents a substantial increase in primary multidrug-resistant TB (P-MDRTB) in the civilian population of Ivanovo from January 1996 through October 1998 and a high prevalence of alcoholism, previous incarceration, unemployment, and history of homelessness among persons infected with both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.

摘要

俄罗斯联邦的结核病发病率从1991年的每10万人34例稳步上升至1998年的每10万人78例(中央结核病研究所,未发表数据,1999年)。为扭转这一趋势,1995年,在世界卫生组织(WHO)的协助下,联邦和地方政府在伊万诺沃州(1998年人口约130万)实施了一个试点项目,采用WHO的结核病控制策略,即直接观察短程化疗(DOTS),该州位于莫斯科东北165英里(280公里)处。本报告记录了1996年1月至1998年10月期间伊万诺沃市居民中原发性耐多药结核病(P-MDRTB)的大幅增加,以及感染敏感和耐药结核分枝杆菌菌株的人群中酗酒、既往监禁、失业和无家可归史的高患病率。

相似文献

1
Primary multidrug-resistant tuberculosis--Ivanovo Oblast, Russia, 1999.原发性耐多药结核病——俄罗斯伊万诺沃州,1999年
MMWR Morb Mortal Wkly Rep. 1999 Aug 6;48(30):661-4.
2
Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.采用标准化短程化疗“成功”治疗的耐多药结核病病例的复发频率。
Int J Tuberc Lung Dis. 2002 Oct;6(10):858-64.
3
Impact of an effective multidrug-resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model.在艾滋病疫情尚未成熟的背景下,有效的耐多药结核病控制项目的影响:系统动力学模拟模型
Int J STD AIDS. 2005 Aug;16(8):560-70. doi: 10.1258/0956462054679124.
4
Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia.俄罗斯奥廖尔州结核病控制示范项目第一年取得了令人鼓舞的成果。
Int J Tuberc Lung Dis. 2003 Nov;7(11):1045-51.
5
Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group.俄罗斯联邦伊万诺沃州结核病控制政策的成本效益分析。伊万诺沃结核病项目研究小组
Bull World Health Organ. 1998;76(5):475-83.
6
Population-based survey for drug resistance of tuberculosis--Mexico, 1997.1997年墨西哥基于人群的结核病耐药性调查。
MMWR Morb Mortal Wkly Rep. 1998 May 15;47(18):371-5.
7
Mycobacterium tuberculosis in Taiwan.台湾的结核分枝杆菌。
J Infect. 2006 Feb;52(2):77-85. doi: 10.1016/j.jinf.2005.08.008. Epub 2005 Oct 10.
8
Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia.俄罗斯萨马拉地区平民和监狱结核病患者的耐药率及危险因素分析
Thorax. 2005 Feb;60(2):130-5. doi: 10.1136/thx.2004.026922.
9
Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.俄罗斯托木斯克市耐多药结核病的治疗:制定解决贫困与疾病之间联系的项目。
Ann N Y Acad Sci. 2008;1136:1-11. doi: 10.1196/annals.1425.009. Epub 2007 Oct 22.
10
Directly observed treatment, short-course strategy and multidrug-resistant tuberculosis: are any modifications required?直接观察治疗短程策略与耐多药结核病:是否需要进行任何调整?
Bull World Health Organ. 2000;78(2):238-51.

引用本文的文献

1
Prevalence and Determinants of Multidrug-Resistant Tuberculosis in Makkah, Saudi Arabia.沙特阿拉伯麦加耐多药结核病的患病率及决定因素
Infect Drug Resist. 2020 Nov 10;13:4031-4038. doi: 10.2147/IDR.S277477. eCollection 2020.
2
Primary bacillary resistance in multidrug-resistant tuberculosis and predictive factors associated with cure at a referral center in São Paulo, Brazil.巴西圣保罗一家转诊中心耐多药结核病的原发性杆菌耐药性及与治愈相关的预测因素
J Bras Pneumol. 2019 Mar 11;45(2):e20180075. doi: 10.1590/1806-3713/e20180075.
3
Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?
在结核病诊断检测中,我们是否除了需要检测利福平耐药外,还需要检测异烟肼耐药?
PLoS One. 2014 Jan 3;9(1):e84197. doi: 10.1371/journal.pone.0084197. eCollection 2014.
4
Risk factors associated with MDR-TB at the onset of therapy among new cases registered with the RNTCP in Mumbai, India.印度孟买 RNTCP 登记的新病例中,治疗开始时与 MDR-TB 相关的危险因素。
Indian J Public Health. 2011 Jan-Mar;55(1):14-21. doi: 10.4103/0019-557X.82536.
5
Risk factors for multidrug resistant tuberculosis in Europe: a systematic review.欧洲耐多药结核病的危险因素:一项系统综述
Thorax. 2006 Feb;61(2):158-63. doi: 10.1136/thx.2005.045963. Epub 2005 Oct 27.
6
Impact of DOTS and DOTS-plus on multidrug resistant TB: DOTS-plus strengthens, not weakens, DOTS programmes.直接观察治疗短程化疗(DOTS)及强化DOTS对耐多药结核病的影响:强化DOTS增强而非削弱了DOTS计划。
BMJ. 2003 Jul 19;327(7407):164; author reply 164. doi: 10.1136/bmj.327.7407.164.